
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC — Investor Relations & Filings
Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Cancellation of Listing | 2024-06-06 | English | |
| Updated Shareholder Engagement | 2024-05-31 | English | |
| Updated Shareholder Information | 2024-05-17 | English | |
| Intended Cancellation of Listing | 2024-05-08 | English | |
| Appointment of Phase I Clinical Trial CRO | 2024-04-11 | English | |
| OCT Company Update with Doceo | 2024-04-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 2043885 | Cancellation of Listing | 2024-06-06 | English | ||
| 2040973 | Updated Shareholder Engagement | 2024-05-31 | English | ||
| 2034700 | Updated Shareholder Information | 2024-05-17 | English | ||
| 2030589 | Intended Cancellation of Listing | 2024-05-08 | English | ||
| 2017904 | Appointment of Phase I Clinical Trial CRO | 2024-04-11 | English | ||
| 2013890 | OCT Company Update with Doceo | 2024-04-03 | English | ||
| 2010233 | Oxford Cannabinoid Technologies video with Doceo | 2024-03-26 | English | ||
| 2006010 | Appointment of Hybridan as Adviser | 2024-03-18 | English | ||
| 11232657 | GM Special Business Resolutions | 2024-03-06 | English | ||
| 1997749 | Directorate Appointment | 2024-02-29 | English | ||
| 1997753 | Directorate Changes | 2024-02-29 | English | ||
| 1997849 | Total Voting Rights | 2024-02-29 | English | ||
| 1996543 | TR-1: NOTIFICATION OF MAJOR HOLDINGS | 2024-02-28 | English | ||
| 1996545 | TR-1: NOTIFICATION OF MAJOR HOLDINGS | 2024-02-28 | English | ||
| 1996546 | TR-1: NOTIFICATION OF MAJOR HOLDINGS | 2024-02-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5066/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5066 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5066 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5066 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5066}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC (id: 5066)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.